Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rungthiwa, Kitpermkiat"'
Autor:
Jackrapong Bruminhent, Chavachol Setthaudom, Rungthiwa Kitpermkiat, Sasisopin Kiertiburanakul, Kumthorn Malathum, Montira Assanatham, Arkom Nongnuch, Angsana Phuphuakrat, Pongsathon Chaumdee, Chitimaporn Janphram, Sansanee Thotsiri, Piyatida Chuengsaman, Sarinya Boongird
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients. Participants were vaccinated with two-dose inactivated SARS-CoV-2 vacc
Externí odkaz:
https://doaj.org/article/ffd9d03deea7445daec5a394b27253ff
Autor:
Sarinya Boongird, Chavachol Setthaudom, Rungthiwa Kitpermkiat, Somsak Prasongtanakij, Supanart Srisala, Piyatida Chuengsaman, Arkom Nongnuch, Montira Assanatham, Sasisopin Kiertiburanakul, Kumthorn Malathum, Angsana Phuphuakrat, Jackrapong Bruminhent
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1064 (2022)
The durability of a three-dose extended primary series of COVID-19 vaccine in dialysis patients remains unknown. Here, we assessed dynamic changes in SARS-CoV-2-specific humoral and cell-mediated immunity at baseline, 3 months, and 6 months after the
Externí odkaz:
https://doaj.org/article/7e9cec59d681430ca3794372eeb40dbb
Autor:
Rungthiwa Kitpermkiat1, Sansanee Thotsiri1, Nuttaporn Arpornsujaritkun2, Premsant Sangkum3, Pichika Chantrathammachart4, Pimpun Kitpoka5, Duangtawan Thammanichanond5, Tanist Virankabutra6, Surasak Kantachuvesiri1 surasak.kan@mahidol.ac.th
Publikováno v:
American Journal of Case Reports. 7/17/2022, Vol. 23, p1-6. 6p.
Autor:
Rungthiwa Kitpermkiat, Chavachol Sethaudom, Jackrapong Bruminhent, Salinnart Phanprasert, Piyatida Chuengsaman, Kumthorn Malathum, Sasisopin Kiertiburanakul, Arkom Nongnuch, Montira Assanatham, Sarinya Boongird, Angsana Phuphuakrat
Publikováno v:
Kidney International. 100:1136-1138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40ef2d06454b9c4b6b4d3fe4dc35ec3e
https://doi.org/10.1016/j.kint.2021.08.007
https://doi.org/10.1016/j.kint.2021.08.007
Autor:
Rungthiwa Kitpermkiat, Jackrapong Bruminhent, Chavachol Setthaudom, Piyatida Chuengsaman, Sasisopin Kiertiburanakul, Kumthorn Malathum, Montira Assanatham, Arkom Nongnuch, Angsana Phuphuakrat, Pongsathon Chaumdee, Chitimaporn Janphram, Sansanee Thotsiri, Sarinya Boongird
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Patients with end-stage kidney disease (ESKD) are at risk of coronavirus disease 2019 infection and its associated complications. A previous study demonstrated that patients with ESKD on dialysis generated suboptimal humoral immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a74050be05dfe7feee2c98418fc7396c
https://doi.org/10.1093/ndt/gfac066.093
https://doi.org/10.1093/ndt/gfac066.093
Autor:
Jackrapong Bruminhent, Chavachol Setthaudom, Rungthiwa Kitpermkiat, Sasisopin Kiertiburanakul, Kumthorn Malathum, Montira Assanatham, Arkom Nongnuch, Angsana Phuphuakrat, Pongsathon Chaumdee, Chitimaporn Janphram, Sansanee Thotsiri, Piyatida Chuengsaman, Sarinya Boongird
Publikováno v:
Scientific reports. 12(1)
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients. Participants were vaccinated with two-dose inactivated SARS-CoV-2 vaccine (V2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96a96da2fbf242c7b1579ba0280f894c
https://pubmed.ncbi.nlm.nih.gov/35246578
https://pubmed.ncbi.nlm.nih.gov/35246578
Autor:
Rungthiwa Kitpermkiat, Arkom Nongnuch, Salinnart Phanprasert, Piyatida Chuengsaman, Montira Assanatham, Angsana Phuphuakrat, Kumthorn Malathum, Sasisopin Kiertiburanakul, Chavachol Setthaudom, Jackrapong Bruminhent, Sarinya Boongird, Andrew Davenport
Publikováno v:
Infectious Diseases and Therapy
INTRODUCTION Patients with end-stage kidney disease (ESKD) are at risk of severe coronavirus disease and mortality. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inactivated whole-virus vaccine in patients with ESKD h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4eaf7e35814012dc71c2640e38d2825
https://pubmed.ncbi.nlm.nih.gov/34859359
https://pubmed.ncbi.nlm.nih.gov/34859359